Mechanism of GPCR-directed autoantibodies in diseases

Advances in Experimental Medicine and Biology

Volumn 749, Issue , 2012, Pages 187-199

  Unal, Hamiyet ^a   Jagannathan, Rajaganapathi ^a   Karnik, Sadashiva S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BRADYKININ B2 RECEPTOR; CALCIUM SENSING RECEPTOR; G PROTEIN COUPLED RECEPTOR; LOSARTAN; METABOTROPIC RECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; RHODOPSIN; SEROTONIN 4 RECEPTOR; THYROTROPIN RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CHAGAS DISEASE; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SEQUENCE; HODGKIN DISEASE; HUMAN; HYPERTENSION; INTRACELLULAR SIGNALING; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84863740185     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3381-1_13     Document Type: Conference Paper

References (39)

1. Abd Alla S, Quitterer U, Grigoriev S, Maidhof A, Haasemann M, Jarnagin K, Müller-Esterl W (1996) Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing de fi ned by anti-peptide antibodies. J Biol Chem 271:1748-55. doi: 10.1074/jbc.271.3.1748
2. Ahuja S, Hornak V, Yan EC, Syrett N, Goncalves JA, Hirshfeld A, Ziliox M, Sakmar TP, Sheves M, Reeves PJ, Smith SO, Eilers M (2009) Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. Nat Struct Mol Biol 16:168-175. doi: 10.1038/nsmb.1549
3. Biondi B, Kahaly GJ (2010) Cardiovascular involvement in patients with different causes of hyperthyroidism. Nat Rev Endocrinol 6:431-43. doi: 10.1038/nrendo.2010.105
4. Borda T, Gomez R, Berría MI, Sterin-Borda L (2004) Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients sera. Glia 45:144-154. doi: 10.1002/glia.10312
5. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) High-resolution crystal structure of an engineered human b 2-adrenergic G-protein-coupled receptor. Science 318:1258-1265. doi: 10.1126/science.1150577
6. Coesmans M, Smitt PA, Linden DJ, Shigemoto R, Hirano T, Yamakawa Y, van Alphen AM, Luo C, van der Geest JN, Kros JM, Gaillard CA, Frens MA, de Zeeuw CI (2003) Mechanisms underlying cerebellar motor de fi cits due to mGluR1-autoantibodies. Ann Neurol 53:325-336. doi: 10.1002/ana.10451
7. Colvin RB, Smith RN (2005) Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5:807-817. doi: 10.1038/nri1702
8. Dechend R, Homuth V, Wallukat G, Kreuzer J, Park JK, Theuer J, Juepner A, Gulba DC, Mackman N, Haller H, Luft FC (2000) AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101:2382-2387
9. Dechend R, Viedt C, Müller DN, Ugele B, Brandes RP, Wallukat G, Park JK, Janke J, Barta P, Theuer J, Fiebeler A, Homuth V, Dietz R, Haller H, Kreuzer J, Luft FC (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107:1632-9. doi: 10.1161/01.CIR.0000058200.90059.B1
10. Dragun D (2007) The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection. Pediatr Nephrol 22:911-914. doi: 10.1007/s00467-007-0452-z
11. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat GN (2005) Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 352:558-569. doi: 10.1038/nri1702
12. Eftekhari P, Sallé L, Lezoualch F, Mialet J, Gastineau M, Briand JP, Isenberg DA, Fournié GJ, Argibay J, Fischmeister R, Muller S, Hoebeke J (2000) Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 30:2782-2790. doi:10.1002/1521-4141(200010)30:10 3.0.CO;2-9
13. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256-1272. doi: 10.1124/mol.63.6.1256
14. Gavalas NG, Kemp EH, Krohn KJI, Brown EM, Watson PF, Weetman AP (2007) The calciumsensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92:2107-2114. doi: 10.1210/jc.2006-2466
15. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S (2001) Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 37:418-424. doi: 10.1016/S0735-1097(00)01109-8
16. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EYT, Lane JR, IJzerman AP, Stevens RC (2008) The 2.6 Angstrom crystal structure of a human A 2A adenosine receptor bound to an antagonist. Science 322:1211-1217. doi: 10.1126/science.1164772
17. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ (2004) Direct evidence for a b 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419-1429. doi: 10.1172/JCI20149
18. Karnik SS, Gogonea C, Saad Y, Patil S, Takezako T (2003) Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol Metab 14:431-437. doi: 10.1016/j. tem.2003.09.007
19. Kimura A, Sakurai T, Suzuki Y, Hayashi Y, Hozumi I, Watanabe O, Arimura K, Takahashi Y, Inuzuka T (2007) Autoantibodies against glutamate receptor epsilon2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis. Eur Neurol 58:152-158. doi: 10.1159/000104716
20. Klco JM, Wiegand CB, Narzinski K, Baranski TJ (2005) Essential role for the second extracellular loop in C5a receptor activation. Nat Struct Mol Biol 12:320-326. doi: 10.1038/nsmb913
21. Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339-357. doi: 10.1038/nrd2518
22. Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67-76. doi: 10.1016/S1474- 4422(09)70324-2
23. Liao YH, Wei YM, Wang M, Wang ZH, Yuan HT, Cheng LX (2002) Autoantibodies against AT1- receptor and a1-adrenergic receptor in patients with hypertension. Hypertens Res 25:641-646
24. Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation 89:2760-2767
25. Massotte D, Kieffer BL (2005) The second extracellular loop: a damper for G protein-coupled receptors? Nat Struct Mol Biol 12:287-288. doi: 10.1038/nsmb0405-287
26. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Crystal structure of rhodopsin: a G-protein-coupled receptor. Science 289:739-745. doi: 10.1126/science.289.5480.739
27. Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP (2008) Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454:183-187. doi: 10.1038/nature07063
28. Perez DM (2003) The evolutionarily triumphant G-protein-coupled receptor. Mol Pharmacol 63:1202-1205. doi: 10.1124/mol.63.6.1202
29. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM (1999) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716. doi: 10.1210/er.19.6.673
30. Riemekasten G, Philippe A, Näther M, Slowinski T, Müller DN, Heidecke H, Matucci-Cerinic M, Czirják L, Lukitsch I, Becker M, Kill A, van Laar JM, Catar R, Luft FC, Burmester GR, Hegner B, Dragun D (2010) Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 70:530-536. doi: 10.1136/ard.2010.135772
31. Roberts JM (2000) Angiotensin-1 receptor autoantibodies: a role in the pathogenesis of preeclampsia? Circulation 101:2335-2337
32. Rosenbaum DM, Rasmussen SG, Kobilka BK (2009) The structure and function of G-proteincoupled receptors. Nature 459:356-363. doi: 10.1038/nature08144
33. Rossi MA, Tanowitz HB, Malvestio LM, Celes MR, Campos EC, Blefari V, Prado CM (2010) Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Negl Trop Dis 4:e674. doi: 10.1371/journal.pntd.0000674
34. Shi L, Javitch JA (2004) The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci USA 101:440-5. doi: 10.1073/pnas.2237265100
35. Stavrakis S, Yu X, Patterson E, Huang S, Hamlett SR, Chalmers L, Pappy R, Cunningham MW, Morshed SA, Davies TF, Lazzara R, Kem DC (2009) Activating autoantibodies to the beta-1 adrenergic and M2 muscarinic receptors facilitate atrial fi brillation in patients with graves hyperthyroidism. J Am Coll Cardiol 54:1309-1316. doi: 10.1016/j.jacc.2009.07.015
36. Unal H, Jagannathan R, Bhat MB, Karnik SS (2010) Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor. J Biol Chem 21:16341-50. doi: 10.1074/jbc. M109.094870
37. Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW (1957) Chronic thyroiditis and autoimmunization. J Am Med Assoc 164:1439-1447. doi: 10.1001/jama.1957.02980130015004
38. Xia Y, Ramin SM, Kellems RE (2007) Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50:269-275. doi: 10.1161/ HYPERTENSIONAHA.107.091322
39. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y (2008) Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 14:855-62. doi: 10.1038/nm.1856